Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes
Qi Peng(Shanghai Jiao Tong University), Jiaming Fan(Qilu University of Technology), Ailong Huang(Chongqing Medical University), Lan Zhou(Zhejiang A & F University), Jinyong Luo(Ministry of Education), Tong‐Chuan He(Northwestern University), Hao Wang(University of Mississippi), Yetao Luo(Children's Hospital of Chongqing Medical University), Bin Chen(Children's Hospital of Chongqing Medical University), Qiong Shi(Hebei Medical University), Ying Zhu(Jiangsu Cancer Hospital), Jinghong Wu(Children's Hospital of Chongqing Medical University), Guowei Zuo(Chongqing Medical University), Yaguang Weng(Children's Hospital of Chongqing Medical University)
Cited by 38
Related Papers
Antibody responses to SARS-CoV-2 in patients with COVID-19
|Nature Medicine|2020|3.1k
Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs)
|Cellular Physiology and Biochemistry|2017|2.8k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Is a p53-Regulated Inhibitor of G2/M Progression
|Molecular Cell|1997|1.2k
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
|Nature Protocols|2007|869